Scientists report encouraging preclinical results of a small molecule called DPM-1001 that robustly reduces copper levels in cells and tissues. It is a potential treatment for Wilson's disease, a serious genetic illness.
Dr. Nick Tonks describes how the serendipity that is inherent to basic research played its part.
More info: [ Ссылка ]
![](https://s2.save4k.ru/pic/DVlUAwqMaLs/mqdefault.jpg)